Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #global #pharmaceutical #industry

Posted On Jan 7 2018 by

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …


Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #contract #manufacturing #pharma

Posted On Sep 30 2017 by

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …


German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune #pharma #gossip

Posted On Aug 19 2017 by

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …


Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #pharma #executive #search

Posted On Jul 8 2017 by

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …


German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune #cardiome #pharma #corp

Posted On Jul 6 2017 by

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …


Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #medicinal #chemistry

Posted On May 28 2017 by

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …


German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune #cmc #pharma

Posted On Apr 23 2017 by

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …


German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune #pharma #pharmaceutical #company

Posted On Mar 24 2017 by

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …


Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #sk #pharma

Posted On Feb 11 2017 by

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …


German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune #new #pharmaceuticals

Posted On Feb 5 2017 by

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …